Drug Shortage Report for ODAN-SPOR-HC
Report ID | 1041 |
Drug Identification Number | 00626600 |
Brand name | ODAN-SPOR-HC |
Common or Proper name | Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP |
Company Name | ODAN LABORATORIES LTD |
Market Status | DORMANT |
Active Ingredient(s) | Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate |
Strength(s) | 10 mg/mL 3.5 mg/mL 10,000 unit/mL |
Dosage form(s) | Suspension |
Route of administration | Otic |
Packaging size | 10 mL |
ATC code | S02CA |
ATC description | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-04-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 2 of 2